Trinity Biotech ADR buy StockNews.com
Start price
26.02.23
/
50%
€0.99
Target price
26.02.24
-
Performance (%)
-56.95%
End price
27.02.24
-
Summary
This prediction is currently being closed. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -56.95%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trinity Biotech ADR | - | - | - | - |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% | 51.849% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% | 86.850% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% | 63.321% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% | 66.112% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten